Obsidian Financial’s Morning Market News for Friday October 14, 2011: Easton Pharmaceuticals, Goldman Sachs Group Inc., Nordstrom Inc., Lincoln Financial Group, Opko Health

October 14, 2011 - OFinancialinc.com announces the following stocks to its Morning Market News: Easton Pharmaceuticals (OTC: EAPH), Goldman Sachs Group Inc. (NYSE: GS), Nordstrom Inc. (NASDAQ: JWN), Lincoln Financial Group (NYSE: LNC), Opko Health (NYSE: OPK)

OFinancialinc.com, the investor's choice for small-cap alerts, provides stock alerts of the most active small to big cap stocks for early signs of potentially big stock moves. Early timing is critical for catching these potentially explosive stock moves. To receive our FREE "OFC Stock Alert Newsletter" and get more early alerts, please visit our website: OFinancialinc.com.

Easton Pharmaceuticals (OTC: EAPH), a specialty pharmaceutical company that designs, develops, and markets a premium array of topically-delivered therapeutic healthcare products announced yesterday 10/13/11, the appointment of Daniel Bagi, MD as consultant to spearhead Viorra regulatory, patent and product launch initiatives in Mexico.

Dr. Bagi is the lead contact with BMV Medica S.A. de C.V. (BMV) a regulatory & licensing consultantancy company in Mexico, which has been engaged to begin the process of submitting applications to obtain regulatory approvals for its first product, VIORRA, in that country. Dr. Bagi has developed substantial relationships in Mexico for other products over the last 20+ yrs. In addition, Dr. Bagi understands the local regulatory process and will be working closely with BMV to have Viorra approved for sale. With his astute understanding of the market in Mexico, Dr. Bagi will assist Easton Pharmaceuticals on all aspects of marketing Viorra and other Easton products. Along with his Mexican contacts, Dr. Bagi has nurtured contacts in markets within East Asia, which the company anticipates on eventually utilizing. Aside from his appointment as consultant to Easton Pharmaceuticals, the company has entered into discussions with Dr. Bagi for a director and officer position within the company.

To view the full press release for Easton Pharmaceuticals (OTC: EAPH), CLICK HERE or visit OFinancialinc.com

 

Other stocks highlighted include:

Goldman Sachs Group Inc. (NYSE: GS) persuaded a judge to throw out shareholders’ claims that the investment bank’s compensation system improperly rewarded employees for taking risks that hurt the firm’s stock price. Delaware Chancery Court Judge Sam Glasscock concluded Oct. 12, 2011 that Goldman Sachs’s board acted properly in setting up a pay plan for the fifth-biggest U.S. bank. The judge dismissed a consolidated investor lawsuit claiming the plan wrongly awarded billions of dollars in bonuses to executives and employees, including Chairman Lloyd Blankfein, even as the firm’s market value declined by $50 billion since 1999. Goldman Sachs, which set a Wall Street pay record in 2007, faced criticism from politicians and labor unions for its compensation practices after getting taxpayer aid during the financial crisis. Goldman Sachs agreed to pay $550 million, the largest penalty ever levied by the SEC against a Wall Street firm, to resolve claims that marketing materials about the investments had “incomplete information.” The bank didn’t admit wrongdoing as part of the accord.

Nordstrom Inc. (NASDAQ: JWN) wants to change the statistic that eight out of ten women wear the wrong bra size. Beginning Thursday, October 20 through Saturday, October 22, customers are invited to meet with a certified fit expert at Nordstrom for a complimentary fitting and see what a difference the right bra can make in helping them look and feel great. For every bra purchased at the event, Nordstrom and participating brands will donate $2.00 to Susan G. Komen for the Cure® to help support their efforts to imagine a world without breast cancer, as well as lifesaving outreach programs for women.

Lincoln Financial Group (NYSE: LNC) announced yesterday 10/13/11, the introduction of the LVIP Protected Profile Funds, a target-date fund-of-funds investment option available through its micro-to-small market retirement plan solution. Designed to adjust its equity allocation in response to prevailing market conditions, the multi-manager investment approach of Protected Profile Funds offers investors access to both capital protection and volatility management within a target-date fund. Unique advantages include a simplified process to help investors achieve a diversified portfolio and exposure to a wide variety of asset classes, regions and investments styles. "Protected Profile Funds help address plan participants' concerns over sustained losses during a market downswing, as the glide path can adjust its equity and fixed income allocation in response to varying market conditions," says Eric Levy, Head of Defined Contribution Products.  "We're confident that this innovative and simple long-term investing approach seeks to provide a safeguard retirement savings in good times and bad."

Opko Health (NYSE: OPK) - A scientist at the Scripps Research Institute in Jupiter won a $4.2 million grant from the National Institutes of Health to fund Type 1 diabetes research today, 10/14/11. Chemistry professor Thomas Kodadek is the principal of the study, which is being done in collaboration with researchers at Miami-based Opko Health (NYSE: OPK) and the University of Miami. The grant will fund their work over four years. Kodadek and his team are looking for ways to selectively block the autoimmune disease without shutting down or damaging the entire immune response. It could also lead to a new way to diagnose Type 1 diabetes. His approach will focus on peptoids, a synthetic molecule that will be used to identify the antibodies they want to single out.

About OFinancialInc.com:

OFinancialInc.com, a leader in corporate communications and finance, provides investors with a wide-ranging set of financial tools, including original stock market commentary, stock quotes, interactive charts, portfolio watch, live chat and message boards, plus the latest news, press releases, investment opinions, and research reports for all companies highlighted on the site. Visit http://StockPromoters.com for more details.

All material herein was prepared by Obsidian Financial Communications, Inc. (OFC) based upon information believed to be reliable. The information contained herein is not guaranteed by OFC to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. OFC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://OFinancialinc.com or mentioned herein. Easton Pharmaceuticals (OTC: EAPH) - OFC has not been compensated for EAPH. In addition to any compensation mentioned above, additional compensation can be equal to ten percent of any newly issued or registered securities of the profiled companies. OFC's affiliates, officers, directors and employees may own shares and intend to buy and sell additional shares of the companies mentioned herein and may profit in the event those shares rise in value. OFC will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. To see OFC's full disclaimer / compensation, please visit our web site:  http://ofinancialinc.com/disclaimer

 

Joe Farrar, CEO, Obsidian Financial Communications, Inc.

OFinancialInc.com

631.675.6932